The ROE as of September 2024 (TTM) for Prime Medicine, Inc. (PRME) is -113.34%

According to Prime Medicine, Inc.’s latest financial reports and current stock price. The company's current ROE is -113.34%. This represents a change of 270.43% compared to the average of -30.60% of the last 4 quarters.

Prime Medicine, Inc. (PRME) Historical ROE (quarterly & annually)

How has PRME ROE performed in the past?

The mean historical ROE of Prime Medicine, Inc. over the last ten years is -73.74%. The current -113.34% ROE has changed 53.71% with respect to the historical average. Over the past ten years (40 quarters), PRME's ROE was at its highest in in the December 2022 quarter at 13.38%. The ROE was at its lowest in in the December 2023 quarter at -49.33%.

Prime Medicine, Inc. (PRME) ROE by Quarter and Year

Discovering the peaks and valleys of Prime Medicine, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Prime Medicine, Inc. (PRME) Average ROE

How has PRME ROE performed in the past?

The current ROE of Prime Medicine, Inc. (PRME) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Prime Medicine, Inc. (PRME) ROE vs. Peers

How is PRME’s ROE compared to its peers?

Prime Medicine, Inc.’s ROE is greater than Beam Therapeutics Inc. (-16.22%), greater than Caribou Biosciences, Inc. (-34.76%), greater than Intellia Therapeutics, Inc. (-49.70%), greater than Sana Biotechnology, Inc. (-71.60%), greater than Reneo Pharmaceuticals, Inc. (-62.53%), greater than Ginkgo Bioworks Holdings, Inc. (-86.10%), less than Ocean Biomedical, Inc. (567.07%), less than Royalty Pharma plc (10.50%), greater than Editas Medicine, Inc. (-62.61%), greater than CRISPR Therapeutics AG (-13.85%), greater than Verve Therapeutics, Inc. (-35.20%), greater than Theseus Pharmaceuticals, Inc. (-24.51%), greater than aTyr Pharma, Inc. (-56.83%), greater than Relay Therapeutics, Inc. (-43.66%), greater than Century Therapeutics, Inc. (-65.37%), greater than Blueprint Medicines Corporation (-85.25%),

Build a custom stock screener for Prime Medicine, Inc. (PRME) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Prime Medicine, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Prime Medicine, Inc. (PRME) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Prime Medicine, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.